Market Research Report

Global Cell-based Assay Market Research Report: Forecast (2024-2029)

By Products & Services (Consumables, Instruments & Software, Services), By Application (Drug Discovery, Absorption, Distribution, Metabolism and Excretion (ADME) Studies, Others (B...asic Research, Predictive Toxicology Studies, etc.)), By Technology (Automated Handling, Flow Cytometry, Others (Label-free Detection, High-throughput Screening, etc.)), By End User (Pharmaceutical & Biotechnological Companies, Academic & Government Institutes, Contract Research Organizations, Others (Research institutes, Contract Development and Manufacturing Organizations (CDMOs), etc.)), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (Cell Signaling Technology, Inc., Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Lonza Group, Abcam plc., Becton, Dickenson and Company, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Cayman Chemical, R&D Systems, Inc., AnaSpec, Enzo Life Sciences, Inc., Menarini Silicon Biosystems, Inc., and Others) Read more

  • Healthcare
  • Oct 2023
  • 196
  • HC55046

Market Definition

Cell-based Assay are cellular systems used for assessing the biological activity or response to various substances, such as drugs, chemicals, or compounds. These assays are often cultured in vitro to measure specific cellular functions, including cell viability, proliferation, and the interaction between molecules and cellular pathways. The surging research to identify drug efficacy & toxicity and screening for potential therapeutic agents is facilitating the demand for cell-based assays.

Market Insights & Analysis: Global Cell-based Assay Market (2024-29):

The Global Cell-based Assay Market is anticipated to grow at a CAGR of around 8.4% during the forecast period, i.e., 2024-29. The global market size is expected to exceed USD 29 billion by 2029. The factors attributing to the growth in the demand for cell-based assays across the globe are; the rising drug discovery activities by pharmaceutical companies, the surging inclination of consumers towards personalized medicines, and rising government funding and private investments in life sciences and healthcare research.

During the historical years, the number of patients suffering from chronic diseases such as cancer, diabetes, and cardiovascular conditions has significantly increased. According to the International Diabetes Federation, the total number of individuals suffering from diabetes will be 537 million in 2021. In addition, according to the World Health Organization, in 2021, Cardiovascular Diseases (CVDs) were among the leading causes of death globally and resulted in the death of more than 17 million individuals globally. The rise in the incidences of these diseases has notably led pharmaceutical companies such as Sun Pharmaceutical Industries Ltd., Mankind Pharmaceuticals, etc., to emphasize drug discovery, toxicology research, and disease investigations, driving the demand for cell-based assays.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-29
CAGR (2024-2029) 8.4%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Southeast Asia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled Cell Signaling Technology, Inc., Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Lonza Group, Abcam plc., Becton, Dickenson and Company, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Cayman Chemical, R&D Systems, Inc., AnaSpec, Enzo Life Sciences, Inc., Menarini Silicon Biosystems, Inc., and Others
Market Value (2029) USD 29 billion

 

In addition, with the advancement in the pharmaceutical and biotechnology industries, there is a growing emphasis on personalized medicine and targeted therapies, which rely on precise cellular assessments. Cell-based assays play a pivotal role in screening potential drug candidates, evaluating their efficacy, and assessing patient-specific responses. Therefore, the growing need for cell-based assays to support the development of tailored treatments and therapies is also contributing to its increased demand.

Further, the technological advancements in cell-based assays, such as fluorescence, luminescence, and flow cytometry, are expected to significantly enhance assay precision and sensitivity. This would lead to improved data accuracy, increased throughput, and the ability to analyze complex cellular processes more effectively, making these assays more appealing for drug development and research applications in the biotechnology and pharmaceutical sectors, ultimately driving market growth.


Global Cell-based Assay Market Research Report: Forecast (2024-2029)

Global Cell-based Assay Market Driver:

Increasing Demand for Targeted Therapies to Boost the Demand for Cell-based Assay – With progressions in scientific knowledge about diseases, there is a mounting focus on emerging targeted therapies that accurately address specific molecular pathways linked to ailments. The targeted therapies offer precision and effective treatment for diseases such as cancer, auto-immune diseases, etc. Therefore, bio-pharmaceutical companies such as Thermo Fisher Scientific, PerkinElmer, etc., are increasingly developing these targeted therapies to offer accurate treatment to patients suffering from deadly diseases. These targeted therapies are developed using cell-based assays since they provide valuable insights related to drug interfaces, latent side effects, and drug efficacy, driving the Global Cell-based Assay Market.

In addition, these biopharmaceutical companies are also investing in biomarkers for disease diagnosis, disease prognosis, and drug development, which would further stipulate the demand for cell-based assays.

Global Cell-based Assay Market Opportunity:

Personalized Medicine Unlocking Growth Potential in the Market – The rise of personalized medicine presents a significant opportunity in the Global Cell-based Assay Market. As genomics and precision medicine advance, there is a growing focus on tailoring medical treatments to individual patients based on their unique genetic profiles and disease characteristics. The increasing demand for personalized medicine necessitates accurate patient-specific drug assessments. Cell-based assays are crucial tools for evaluating individual drug responses and driving their demand. These assays enable tailored treatment selection, diverse patient population analysis, and data-driven healthcare in the growing personalized medicine market.

  • In 2022, the company, Replimune Group, conducted a trial for the personalized medicine ‘vusolimogene oderparepvec (RP1)’, it developed for the treatment of melanoma patients.

Further, the bio-pharmaceutical companies are also integrating cell-based assays with emerging technologies like organ-on-a-chip and microfluidics to develop personalized medicine. The increasing amalgamation of these technologies with cell-based assays to revolutionize drug development & foster efficiency would consequently enhance the Global Cell-based Assay Market in forthcoming years.

Global Cell-based Assay Market Trend:

Rising Demand for 3D Cell-Based Assays Revolutionizing the Market – Traditional 2D cell cultures have limitations in accurately representing complex in vivo environments. As a result, companies are increasingly adopting and leaning towards the utilization of 3D Cell-based assays. These assays offer a more physiologically relevant approach, mimicking natural tissue microenvironments, which is proving invaluable for drug discovery, disease modeling, and toxicity screening. This shift is driven by the potential for improved outcomes and reduced development costs associated with the use of 3D cell-based assays.

  • In addition, in 2022, the FDA Modernization Act 2.0 was signed into law, allowing the use of organoids and 3D models as alternatives to animal testing for drug investigation.

Further, 3D cell replicas offer additional accurate representation of in-vivo conditions, making them valuable for drug screening and toxicity testing. As a result, researchers and pharmaceutical companies are investing in 3D assays to identify potential drug candidates and assess their safety and efficacy more reliably. Hence, the heightened interest in 3D Cell-based assays is primarily gaining traction in the Global Cell-based Assay market.

Global Cell-based Assay Market (2024-29): Segmentation Analysis

The Global Cell-based Assay Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment. It includes predictions for the period 2024–2029 at the global level. According to the analysis, the market has been further classified as:

Based on Products & Services:

  • Consumables
    • Reagents
    • Assay Kits
  • Microplates
  • Cell Lines
    • Immortalized Cell Lines
    • Primary Cell Lines
    • Stem Cell Lines
  • Probes & Labels
  • Others (Microplates, Pipette Tips, etc.)
  • Instruments & Software
  • Services

Consumables such as reagents, assay kits, cell lines, and probes & labels are likely to dominate the Cell-based Assay Market. These consumables are essential components required for performing research, drug development, and diagnostics across various sectors including pharmaceuticals, biotechnology, and healthcare. In addition, instruments & software also rely on a steady supply of consumables to conduct research, making consumables the foundational and consistently demanded segment in the market.

The pivotal role played by consumables like lipid nanoparticles, buffers, and stabilizers in vaccine development and other cutting-edge biotechnological applications is enhancing the share of the consumables in the Global Cell-based Assay Market.

Based on Technology:

  • Automated Handling
  • Flow Cytometry
  • Others (Label-free Detection, High-throughput Screening, etc.)

Flow cytometry has become a dominant technology in the market due to its versatility and wide range of applications. Flow cytometry offers the advantage of multi-parameter analysis, allowing simultaneous examination of various cellular characteristics in a single experiment. This has made flow cytometry a preferred choice for drug discovery, immunology, and cancer research, where large datasets need to be generated and analyzed.

Companies like Beckman Coulter, BD Biosciences, Thermo Fisher Scientific, etc. are expanding their flow cytometry and cellular assay services through partnerships and acquisitions. These strategic moves enhance demand for flow cytometry by offering a comprehensive range of services, driving innovation, and expanding market reach, thus meeting the evolving needs of biotech, pharmaceutical, and cell/gene therapy sectors. For instance:

  • In 2022, KCAS acquired FlowMetric, a company offering flow cytometry and cellular assay R&D services to biotech, pharmaceutical, and cell/gene therapy sectors, to strengthen their growth and customer service offerings.

The advancements in modern flow cytometry, enabling the analysis of multiple parameters and diverse cellular processes, are poised to drive increased demand. This expanded applicability across research, drug development, personalized medicine, and biotechnology sectors positions flow cytometry as a crucial tool for comprehensive cellular analysis, fostering its growing adoption. As a result, flow cytometry has cemented its position as a powerful tool in life sciences, with applications ranging from basic research to clinical diagnostics and personalized medicine.

Global Cell-based Assay Market (2024-29): Regional Projections

Geographically, the Global Cell-based Assay Market expands across:

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

The demand for Cell-based Assays in North America is influenced by its robust research and pharmaceutical sectors, clinical and diagnostic applications, stringent regulatory requirements, and global industry impact. The prevalence of pharmaceutical companies in North America also enhances the need for cell-based assays for drug discovery & drug development. In addition, the region's comprehensive ecosystem of research, innovation, healthcare, and global influence collectively contributes to its significant demand for cell-based assays.

Government-sponsored research initiatives, such as those by the US NIH and NCI, Canadian CIHR, and Mexican CONACYT, play a pivotal role in advancing cell-based assays. These initiatives fund projects across various disease areas, driving innovation and fostering collaboration among research institutions, academia, and industry. The knowledge and discoveries generated through these initiatives contribute to the increased adoption of cell-based assays in drug development, diagnostics, and personalized medicine, further aiding in creating an opportunistic arena for the North Cell-based Assay Market.

Global Cell-based Assay Market Recent Development:

  • 2023: Lunaphore Technologies and Cell Signaling Technology partnered to enable the use of CST's antibodies on Lunaphore's Comet platform for antibody-based spatial protein analysis. Utilizing fluorescent secondary antibodies, over 1,700 immunohistochemistry-validated antibodies from CST will be applied on the COMET platform for rapid antibody panel development.

Gain a Competitive Edge with Our Global Cell-based Assay Market Report

  1. Global Cell-based Assay Market Report by Markntel Advisors provides a detailed & thorough analysis of market size, growth rate, competitive landscape, and key players. This comprehensive analysis helps business organizations to gain a holistic understanding of the market dynamics & make informed decisions.
  2. This report also highlights current market trends & future projections, allowing business organizations to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  3. Global Cell-based Assay Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, business organizations can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

   A. The Cell-based Assay Market is expected to grow at a CAGR of around 8.4% during 2024-29.

   A. Increasing demand for targeted therapies in drug development is expected to drive the Cell-based Assay Market during 2024-29.

   A. The top players in the Cell-based Assay Market include Cell Signaling Technology, Inc., Danaher Corporation, Thermo Fisher Scientific, Merck KGaA, Lonza Group, Abcam plc., Becton, Dickenson and Company, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Cayman Chemical, R&D Systems, Inc., AnaSpec, Enzo Life Sciences, Inc., Menarini Silicon Biosystems, Inc., and Others.

   A. Flow cytometry is the leading technology expected to hold a dominant share in the Cell-based Assay Market.

   A. Rising demand for 3D cell-based assays revolutionizing the market is the key trend shaping the growth of the Cell-based Assay Market.

   A. Personalized medicine potential is expected to drive the Cell-based Assay Market through 2029.

   A. Reproducibility and standardization challenges in cell-based assays are a possible restraints affecting the growth of the Cell-based Assay Market.

Global Cell-based Assay Market Research Report (2024-2029) - Table of Contents

 

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Cell-based Assay Market Trends & Insights
  5. Global Cell-based Assay Market Dynamics
    1. Drivers
    2. Challenges
  6. Global Cell-based Assay Market Supply Chain Analysis
  7. Global Cell-based Assay Market Patent Analysis
  8. Global Cell-based Assay Market Hotspots & Opportunities
  9. Global Cell-based Assay Market Regulations & Policy
  10. Global Cell-based Assay Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Products & Services
        1. Consumables- Market Size & Forecast 2019-2029, Revenues (USD Million)
          1. Reagents- Market Size & Forecast 2019-2029, Revenues (USD Million)
          2. Assay Kits- Market Size & Forecast 2019-2029, Revenues (USD Million)
            1. Reporter Gene Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)
            2. Cell Growth Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)
            3. Second Messenger Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)           
            4. Cell Death Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)
            5. Other (Ion Channel Assays, Cell Adhesion Assays, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
          3. Microplates
          4. Cell Lines
            1. Immortalized Cell Lines- Market Size & Forecast 2019-2029, Revenues (USD Million)
            2. Primary Cell Lines- Market Size & Forecast 2019-2029, Revenues (USD Million)
            3. Stem Cell Lines- Market Size & Forecast 2019-2029, Revenues (USD Million)
          5. Probes & Labels- Market Size & Forecast 2019-2029, Revenues (USD Million)
          6. Others (Microplates, Pipette Tips, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. Instruments & Software- Market Size & Forecast 2019-2029, Revenues (USD Million)
        3. Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
      2. By Application
        1. Drug Discovery- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. Absorption, Distribution, Metabolism and Excretion (ADME) Studies- Market Size & Forecast 2019-2029, Revenues (USD Million)
        3. Others (Basic Research, Predictive Toxicology Studies, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
      3. By Technology
        1. Automated Handling- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. Flow Cytometry- Market Size & Forecast 2019-2029, Revenues (USD Million)
        3. Others (Label-free Detection, High-throughput Screening, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
      4. By End User
        1. Pharmaceutical & Biotechnological Companies- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. Academic & Government Institutes- Market Size & Forecast 2019-2029, Revenues (USD Million)
        3. Contract Research Organizations- Market Size & Forecast 2019-2029, Revenues (USD Million)
        4. Others (Research institutes, Contract Development and Manufacturing Organizations (CDMOs), etc.) - Market Size & Forecast 2019-2029, Revenues (USD Million)
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      6. By Competitors
        1. Competition Characteristics
        2. Market Share & Analysis
  11. North America Cell-based Assay Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2029, Revenues (USD Million)
      2. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
      3. By Application- Market Size & Forecast 2019-2029, Revenues (USD Million)
      4. By Technology- Market Size & Forecast 2019-2029, Revenues (USD Million)
      5. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
      6. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    4. Canada Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    5. Mexico Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
  12. South America Cell-based Assay Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2029, Revenues (USD Million)
      2. Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
      3. By Application- Market Size & Forecast 2019-2029, Revenues (USD Million)
      4. By Technology- Market Size & Forecast 2019-2029, Revenues (USD Million)
      5. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
      6. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
  13. Europe Cell-based Assay Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2029, Revenues (USD Million)
      2. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
      3. By Application- Market Size & Forecast 2019-2029, Revenues (USD Million)
      4. By Technology- Market Size & Forecast 2019-2029, Revenues (USD Million)
      5. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
      6. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of the Europe
    3. Germany Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    4. The UK Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User - Market Size & Forecast 2019-2029, Revenues (USD Million)
    5. France Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    6. Spain Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    7. Italy Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
  14. The Middle East & Africa Cell-based Assay Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2029, Revenues (USD Million)
      2. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
      3. By Application- Market Size & Forecast 2019-2029, Revenues (USD Million)
      4. By Technology- Market Size & Forecast 2019-2029, Revenues (USD Million)
      5. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
      6. By Country
        1. GCC
        2. South Africa
        3. Rest of the Middle East & Africa
    3. GCC Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    4. South Africa Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
  15. Asia Pacific Cell-based Assay Market Outlook, 2019-2029F
    1. Market Size & Analysis
      1. By Revenue (USD Million)
    2. Market Share & Analysis
      1. By Type- Market Size & Forecast 2019-2029, Revenues (USD Million)
      2. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
      3. By Application- Market Size & Forecast 2019-2029, Revenues (USD Million)
      4. By Technology- Market Size & Forecast 2019-2029, Revenues (USD Million)
      5. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
      6. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Southeast Asia
        6. Australia
        7. Rest of the Asia Pacific
    3. China Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    4. India Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    5. Japan Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By Application- Market Size & Forecast 2019-2029, Revenues (USD Million)
    6. South Korea Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    7. Southeast Asia Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
    8. Australia Cell-based Assay Market Outlook, 2019-2029F
      1. Market Size & Analysis
        1. By Revenue (USD Million)
      2. Market Share & Analysis
        1. By Products & Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
        2. By End User- Market Size & Forecast 2019-2029, Revenues (USD Million)
  16. Global Cell-based Assay Market Key Strategic Imperatives for Success and Growth
  17. Competition Outlook
    1. Company Profiles
      1. Cell Signaling Technology, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Danaher Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Thermo Fisher Scientific
        1.  Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Merck KGaA
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Lonza Group
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Abcam plc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Becton, Dickenson and Company
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Promega Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Bio-Rad Laboratories, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. PerkinElmer Inc. 
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Cayman Chemical
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. R&D Systems, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. AnaSpec
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Enzo Life Sciences, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Menarini Silicon Biosystems, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  18. Disclaimer


Cell-based Assay Market - Segmentation Slide
Place an order
Only market data will be provided in the excel spreadsheet.

USD 3,700

The report will be delivered in PDF format without printing rights. It is advised for a single user.

USD 4,850

The report will be delivered in PDF format with printing rights. It is advised for up to five users.

USD 6,000

The report will be delivered in PDF format with printing rights and excel sheet. It is advised for companies where multiple users would like to access the report from multiple locations

USD 7,500

Request Sample Talk to our Consultant Request Customization
Related Reports